This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

JNNP podcast

By BMJ Group

JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

  1. 1.
    Movement disorders and seizures08/15/2019
    18:08
  2. 2.
    The role of functional neuroimaging in functional neurological disorders07/31/2019
    12:57
  3. 3.
    Emotional processing in functional neurological disorder (FND)06/12/2019
    12:12
  4. 4.
    Can cocoa help with fatigue in MS05/28/2019
    6:59
  5. 5.
    Neurorehabilitation in chronic stroke05/08/2019
    12:47
  6. 6.
    The real patient value04/18/2019
    12:43
  7. 7.
    Medical conferences - what do we get out of them?04/04/2019
    9:30
  8. 8.
    Oral immunotherapies in MS a comparison of efficacy.03/25/2019
    12:12
  1. 9.
    Therapeutic trial design in frontotemporal dementias03/20/2019
    13:05
  2. 10.
    Do genes affect age of onset in ALS?03/11/2019
    9:49
  3. 11.
    The lifetime risk of common neurological disorders in the elderly population02/18/2019
    6:16
  4. 12.
    PMA and PLS: are they really restricted phenotypes?02/04/2019
    8:57
  5. 13.
    Statins and the risk of recurrent intracerebral haemorrhage (ICH) – what does the evidence say?01/21/2019
    12:02
  6. 14.
    Functional impairment and improvement12/10/2018
    28:56
  7. 15.
    Can computational models help us understand complex movement disorders?10/29/2018
    11:51
  8. 16.
    Idiopathic intracranial hypertension: guidelines for diagnosis and management10/08/2018
    14:54
  9. 17.
    Nusinersen for SMA08/29/2018
    10:19
  10. 18.
    Expanding clinical spectrums in both Kennedy's disease and poststroke syndromes08/06/2018
    28:46
  11. 19.
    The use of cannabis in epilepsy, and surgery for tremor07/02/2018
    23:27
  12. 20.
    Epilepsy an evidence update05/31/2018
    20:52
  13. 21.
    The Use of Frankincense Extract In MS04/04/2018
    16:55
  14. 22.
    A new questionnaire to measure quality of life in inflammatory neuropathies03/07/2018
    8:08
  15. 23.
    Marriage and a reduced risk of dementia02/28/2018
    14:47
  16. 24.
    Anti-inflammatory approaches to stroke prevention; monitoring disease progression in ALS02/08/2018
    30:59
  17. 25.
    Nodes and paranodes; alternative treatments in MS01/26/2018
    18:28
  18. 26.
    Pathophysiology of functional neurological disorder12/13/2017
    11:15
  19. 27.
    Is methamphetamine use linked to stroke in young adults?11/28/2017
    9:53
  20. 28.
    Cerebral Amyloid Angiopathy: New Insights For Clinical Practice11/08/2017
    18:34
  21. 29.
    Cortical Influences in ALS10/31/2017
    20:57
  22. 30.
    Intravenous immunoglobulin in CIDP10/23/2017
    11:40
  23. 31.
    Complex inherited neuropathies: a new approach to diagnosis?10/18/2017
    18:21
  24. 32.
    Cerebellum and neurodegeneration; autoantibodies and psychological development in children09/04/2017
    15:36
  25. 33.
    Time Matters - part 2: how the real costs of multiple sclerosis are being concealed08/07/2017
    11:21
  26. 34.
    Survival and cause of death in Multiple Sclerosis07/19/2017
    13:23
  27. 35.
    Time Matters - part 1: delay is “expensive” in all aspects of multiple sclerosis07/10/2017
    11:24
  28. 36.
    Seven tesla MRI In Neurodegenerative Dementias06/16/2017
    11:25
  29. 37.
    Conversational Laughter In Dementia05/05/2017
    13:52
  30. 38.
    Narrative and Neurology: The Andrew Lees Experiment04/06/2017
    32:54
  31. 39.
    April 2017: deconstructing dilemmas in Amyotrophic Lateral Sclerosis and Guillain-Barré Syndrome03/27/2017
    18:14
  32. 40.
    Zika virus and Guillain-Barré Syndrome: what do we know?03/13/2017
    15:01
  33. 41.
    Immunomodulatory therapy in advanced multiple sclerosis02/13/2017
    14:04
  34. 42.
    The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies11/30/2016
    11:06
  35. 43.
    A clinical tool for predicting survival in motor neurone disease11/30/2016
    8:31
  36. 44.
    Latitude and disease severity in Multiple Sclerosis11/15/2016
    11:19
  37. 45.
    Do your kids play rugby? Risks for rugby union players from repeated concussions11/07/2016
    17:52
  38. 46.
    Genetics and the clinical course of multiple sclerosis10/18/2016
    10:32
  39. 47.
    Is it time to focus on the common pathways linking neurodegenerative diseases?10/13/2016
    13:44
  40. 48.
    October 2016 Edition: long-term outcomes after stroke; hereditary and inflammatory neuropathies09/22/2016
    18:39
  41. 49.
    Selective vulnerability in clinical variants of Alzheimer's Disease08/30/2016
    16:02
  42. 50.
    Smoking: a negative prognostic for survival in motor neurone disease patients08/19/2016
    10:22
  43. 51.
    Review: Amyotrophic Lateral Sclerosis and Motor Neuron Syndromes in Asia07/27/2016
    14:51
  44. 52.
    Automated brain volumetrics in multiple sclerosis, plus migraine and psychiatric co-morbidities06/30/2016
    21:36
  45. 53.
    Coffee consumption and multiple sclerosis06/07/2016
    11:04
  46. 54.
    June Edition: Parkinson’s disease and the rate of ALS progression05/24/2016
    22:00
  47. 55.
    Sudden Unexpected Death in Epilepsy: basic mechanisms and implications for prevention04/08/2016
    9:53
  48. 56.
    Re-evaluating the treatment of acute optic neuritis02/10/2016
    19:16
  49. 57.
    BNPA 2015: Spatial Neglect06/08/2015
    5:27
  50. 58.
    BNPA 2015: New theories of memory systems and networks06/08/2015
    10:27
  51. 59.
    BNPA 2015: Phantom phenomena02/24/2015
    5:21
  52. 60.
    Clinical neurology: why this still matters in the 21st century01/27/2015
    11:32
  53. 61.
    Imaging outcomes for trials of remyelination in multiple sclerosis12/11/2014
    11:56
  54. 62.
    BNPA 2014: Oxytocin and social cognition12/02/2014
    6:57
  55. 63.
    BNPA 2014: Schizophrenia and cognition12/02/2014
    8:06
  56. 64.
    Advances in epilepsy surgery11/27/2014
    17:51
  57. 65.
    Brain atrophy and disability progression in multiple sclerosis patients10/13/2014
    11:23
  58. 66.
    BNPA 2014: Joint hypermobilty and autonomic hyperactivity09/17/2014
    5:13
  59. 67.
    BNPA 2014: Post-Ictal psychosis09/17/2014
    5:09
  60. 68.
    BNPA 2014: TREM2 variants and risk of dementia09/17/2014
    4:47
  61. 69.
    Neurosurgical procedures for psychiatric illness09/17/2014
    17:52
  62. 70.
    Can stress trigger Parkinson's? And new criteria for frontotemporal dementia syndromes.08/05/2014
    36:53
  63. 71.
    HIV and multiple sclerosis: beginning to unravel a mystery07/02/2014
    13:26
  64. 72.
    BNPA 2014: Neuropsychiatry of social knowledge and moral motivation06/24/2014
    11:07
  65. 73.
    DBS in essential tremor, and genetic counselling for ALS05/22/2014
    22:34
  66. 74.
    Mortality and morbidity 15 years after hospital admission with mild head injury04/30/2014
    14:18
  67. 75.
    Informed decision making in MS, and the striatum in neurodegeneration04/04/2014
    29:37
  68. 76.
    BNPA special: Autoimmune encephalitis03/14/2014
    10:59
  69. 77.
    BNPA special: The prospects of a vaccine for Alzheimer's disease03/13/2014
    10:08
  70. 78.
    An unusual variant of Guillain–Barré syndrome, and dopamine dysregulation syndrome03/04/2014
    25:57
  71. 79.
    BNPA special: Impulse control disorder in Parkinson's03/03/2014
    8:40
  72. 80.
    Diagnosing and treating functional symptoms01/10/2014
    27:58
  73. 81.
    Solving the case, making the diagnosis: Neurology and detective writing01/09/2014
    19:44
  74. 82.
    Radiation for brain metastases, and the genetics of ischaemic stroke11/26/2013
    27:13
  75. 83.
    Education special: Headache11/26/2013
    19:43
  76. 84.
    Aggressive MS, and disappointment following deep brain stimulation for Parkinson's10/25/2013
    21:04
  77. 85.
    Vitamin D, sunlight, and MS10/15/2013
    10:39
  78. 86.
    Education special: Neurogenetics update10/15/2013
    9:38
  79. 87.
    Diagnosing and treating neuromyelitis optica08/19/2013
    21:28
  80. 88.
    Diagnosing the dementias07/23/2013
    27:57
  81. 89.
    Anti-GQ1b antibody syndrome, and ALS and language deficits07/05/2013
    27:38
  82. 90.
    Striatal cell transplants for Huntington’s disease: where are we now?07/05/2013
    20:27
  83. 91.
    Education special: MS update06/11/2013
    14:39
  84. 92.
    Education special: Peripheral nerve disease update06/11/2013
    20:01
  85. 93.
    Stem cells in neurology, and enlarged perivascular spaces and intracerebral haemorrhage06/11/2013
    33:56
  86. 94.
    Parkinson’s disease subtypes: lost in translation?05/01/2013
    12:50
  87. 95.
    The latest on stroke05/01/2013
    33:48
  88. 96.
    Dopamine agonist withdrawal syndrome05/01/2013
    10:43
  89. 97.
    BNPA 2013: The impact of epilepsy on cognitive function02/18/2013
    11:12
  90. 98.
    BNPA 2013: Psychedelic drugs, magical thinking and psychosis02/18/2013
    6:39
  91. 99.
    BNPA 2013: Decoding consciousness02/18/2013
    3:47
  92. 100.
    BNPA 2013: Epilepsy, depression and anxiety disorders02/18/2013
    11:55
  93. 101.
    BNPA 2013: Brain networks in human epilepsy02/18/2013
    7:15
  94. 102.
    BNPA 2013: Cellular mechanisms of epilepsy02/18/2013
    7:45
  95. 103.
    BNPA 2013: Autoimmunity and neuropsychiatry02/18/2013
    10:55
  96. 104.
    BNPA 2013: Deep brain stimulation for mental illness02/18/2013
    8:49
  97. 105.
    BNPA 2013: The neural correlates of Freudian “repression” in conversion disorder02/18/2013
    7:04
  98. 106.
    BNPA 2013: Effects of early childhood posterior fossa tumours on IQ02/18/2013
    7:34
  99. 107.
    BNPA 2013: Epilepsy and affective disorders, the role of the subgenual prefrontal cortex02/18/2013
    7:33
  100. 108.
    BNPA 2013: Stress and war, and the limits of neuropsychiatry02/18/2013
    9:40
  101. 109.
    BNPA 2013: Childhood stress and risk for later mental disorder02/18/2013
    10:18
  102. 110.
    BNPA 2013: Inflammation and mental illness02/18/2013
    7:40
  103. 111.
    BNPA 2013: Posttraumatic stress disorder and the brain02/18/2013
    9:40
  104. 112.
    BNPA 2013: Equipped to survive, how comprehensive response to threat enables optimal behaviour02/18/2013
    7:46
  105. 113.
    Discovering Emery-Dreifuss muscular dystrophy, and flavour identification in FTLD02/15/2013
    22:13
  106. 114.
    The future of epilepsy research, assessing hemianopia, measuring sensory nerve action potentials02/15/2013
    31:46
  107. 115.
    The Scheltens scale, disability after head injury, and cannabis for multiple sclerosis02/15/2013
    23:03
  108. 116.
    Early days of the Queen Square brain bank; rating dopaminergic replacement therapy response02/15/2013
    31:42
  109. 117.
    Oliver Sacks’s functional paralysis; progressive multifocal leukoencephalopathy02/15/2013
    20:49
  110. 118.
    Recovery after stroke; malingering after concussion02/15/2013
    27:29
  111. 119.
    The future of glioblastoma therapy02/15/2013
    13:47
  112. 120.
    Neurological symptoms from autoimmune syndromes; movement disorders and OCD; counting strokes02/15/2013
    34:32
  113. 121.
    Idiopathic intracranial hypertension; discovering the neurological effects of critical illness02/15/2013
    23:18
  114. 122.
    Diagnostic criteria for CBS; tractography in ALS fifty years ago; better tests for bvFTD02/15/2013
    31:12
  115. 123.
    Surrogate outcomes; CAA and IH; Angela Vincent looks back02/15/2013
    26:01
  116. 124.
    Cerebral amyloid angiopathy; lifestyle and mortality after stroke; motor output patterns02/15/2013
    22:32
  117. 125.
    The early days of chronic fatigue syndrome research; Clues to functional weakness mechanism02/15/2013
    29:37
  118. 126.
    Diagnosing delirium02/15/2013
    12:55
  119. 127.
    Diagnosing conversion disorder; exercise to prevent falls in Parkinson’s patients02/15/2013
    21:27
  120. 128.
    The natural history of Parkinson’s; the latest on MS and latitude01/29/2013
    19:05
  121. 129.
    Athleticism and ALS; understanding peripherally induced movement disorders01/29/2013
    19:05
  122. 130.
    Thrombolysis for elderly stroke patients; disability with organically-unexplained symptoms01/29/2013
    20:26
  123. 131.
    Finger length ratio and ALS; psychotherapy for dizziness01/29/2013
    10:58
  124. 132.
    Frontotemporal dementia reviewed; temporal orientation and dementia01/29/2013
    18:32
  125. 133.
    Dementia and word knowledge; DBS for Parkinson’s01/29/2013
    17:55
  126. 134.
    Genes, vitamin D and MS; hysteria and hypnosis01/29/2013
    17:12
  127. 135.
    Eye movements in motor neurone disease; work and multiple sclerosis01/29/2013
    15:54
  128. 136.
    October 201001/29/2013
    15:43
  129. 137.
    Predicting adjustment to an ALS diagnosis01/29/2013
    15:43
  130. 138.
    Microbleeds and abuse in dementia01/29/2013
    14:06
  131. 139.
    Migrane co-morbidities01/29/2013
    14:06
  132. 140.
    The SCAN rule01/29/2013
    11:00
  133. 141.
    Epilepsy and driving; Self awareness in dementia01/29/2013
    18:17
  134. 142.
    Pregnancy and MS01/29/2013
    13:52

Listen to JNNP podcast now.

Listen to JNNP podcast in full in the Spotify app